Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

NCT01318122 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Alogliptin and pioglitazone
DRUG: Alogliptin and pioglitazone

Sponsor

Takeda